Reimagine How Omnichannel Integrates
Sales Representatives

Recent data suggests that in-person detailing to HCPs will never return to pre-pandemic levels.

PHYSICIAN INTERACTIONS WITH PHARMA SALES REPS POST-COVID-19

Physician's Poll Question:
Will in-person physician interactions return to pre-pandemic levels post Covid-19?
66%
No, there will be a mix of in-person and virtual meetings
25%
Yes, back to the same levels
9%
No - all meetings will be virtual
Source: GlobalData, May 2021

A recent survey sites that 66% of senior executives at global pharma companies believe that companies will move away for traditional sales rep model due to restricted access, virtual interaction, and perceived low ROI.

Source: McKinsey Furture of Organization Survey. Feb 21 (n=50)

Reduced Access and Vacancies Negatively Impact Share

Despite REDUCED FREQUENCY OF INTERACTIONS OR VACANCIES, HCPs still need and expect support from brands and brands still need to market their products.

:Data Driven Solutions

Our proprietary, sophisticated platform that allows marketing teams to centralized strategy, messaging and tactic selection, while empowering Reps to launch personalized messaging journeys to their HCPs. The best part is Rep360 integrates seamlessly with your existing CRM system.
Vacancy Management

When no Rep coverage is available

LEARN MORE
Rep Empower

For forward-thinking Reps who engage in true territory management

LEARN MORE
Conversation Continuum

Support in-person selling with automated non-personal promotion

LEARN MORE
C.O.V.E.R

For Low and No-See HCPS

LEARN MORE

Vacancy Management Program

Quickly launch non-personal promotion to help offset share loss when territory goes vacant

The CHALLENGE

  • When a territory goes vacant, share decline begins at a rapid pace

The SOLUTION

  • Offset share loss through a coordinated multichannel effort using non-personal promotion (NPP)
  • Flexibility in messaging type based on share drivers (samples, access support or clinical differentiation and key brand attributes)

The IMPACT

  • Overall Rx share loss went from a 35% share loss to a 20% loss in volume where the BioPharm VMP was activated

Rep Empower

Allows for the localization of tactical marketing driven by Reps

The CHALLENGE

  • Engagement strategies need innovation to lift share
  • Rep needs to increase credibility and preserve relationships

The SOLUTION

  • BP’s Rep Empower solution allows Marketing Teams to manage strategy, messaging and tactic selection while giving reps the automated tools that need to send personalized, marketing journeys to their HCPs

The IMPACT

  • Reps stays top-of-mind by controlling the conversation and delivery of NPP messaging that engaging and educates their HCPs

Conversation Continuum

Automatically trigger communications based on data captured by a Rep during a sales call

The CHALLENGE

  • Time between detailing goes from weeks to a couple months due to restricted access
  • Reps needs to communicate credible and relevant messaging between visits to maintain relationships

The SOLUTION

  • Our Platform coordinates a sustained NPP journey post-call
  • When a representative completes a sales call, they log-in information into an SFA, like Veeva
  • Platform connects to the SFA, pulls completed call data
  • Triggers non-personal promotion to HCPs based on what was discussed during call

The IMPACT

  • HCP receives relevant messaging based on last discussion with Rep
  • Drive greater impact by coordinating sustained, non-personal promotion post-call

C.O.V.E.R.

Build & launch advanced, personalized journeys for Reps

The CHALLENGE

  • Representatives need new way to engage HCPs where access is restricted, declining, or no rep coverage is available

The SOLUTION

  • Our Platform allows Marketing Teams to create and deploy multichannel journeys on behalf of representatives
  • Targeting low-see and no-see HCPs, provides enhanced support while still allowing them to be “at the center” of the interaction

The IMPACT

  • Multichannel messaging engages and educates HCPs in low-see/no-see territories
  • Opportunity to gain new prescribers in territories that don’t warrant a sales rep interaction